| A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers (NCT01248052) | Eli Lilly and Company | 2010-11-01 |
| A Study of LY2584702 in Solid Tumors (NCT01241461) | Eli Lilly and Company | 2010-11-01 |
| A Safety Study in Participants With Major Depressive Disorder (NCT01155661) | Eli Lilly and Company | 2010-10-01 |
| A Study of Olaratumab in Soft Tissue Sarcoma (NCT01185964) | Eli Lilly and Company | 2010-10-01 |
| A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together. (NCT01243957) | Eli Lilly and Company | 2010-10-01 |
| A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib (NCT01140347) | Eli Lilly and Company | 2010-10-01 |
| Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject (NCT01236105) | Eli Lilly and Company | 2010-10-01 |
| A Study of Duloxetine in Elderly Generalized Anxiety Disorder (NCT01118780) | Eli Lilly and Company | 2010-10-01 |
| A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes (NCT01159938) | Eli Lilly and Company | 2010-10-01 |
| A Study of LY900010 in Erectile Dysfunction (NCT01160289) | Eli Lilly and Company | 2010-10-01 |
| A Study of LY2216684 in Participants With Impaired Hepatic Function (NCT01241435) | Eli Lilly and Company | 2010-10-01 |
| Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance (NCT01237899) | Eli Lilly and Company | 2010-10-01 |
| A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy (NCT01185353) | Eli Lilly and Company | 2010-10-01 |
| A Study of Olaratumab (IMC-3G3) in Prostate Cancer (NCT01204710) | Eli Lilly and Company | 2010-10-01 |
| A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients (NCT01209832) | Eli Lilly and Company | 2010-09-01 |
| A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms (NCT01139762) | Eli Lilly and Company | 2010-09-01 |
| A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT01160744) | Eli Lilly and Company | 2010-09-01 |
| A Study in Benign Prostatic Hyperplasia (NCT01152190) | Eli Lilly and Company | 2010-09-01 |
| A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus (NCT01215968) | Eli Lilly and Company | 2010-09-01 |
| Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors (NCT01199822) | Eli Lilly and Company | 2010-09-01 |
| A Study in Advanced Cancer (NCT01226485) | Eli Lilly and Company | 2010-09-01 |
| A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's (NCT01148498) | Eli Lilly and Company | 2010-08-01 |
| A Study of Ramucirumab or Icrucumab in Colorectal Cancer (NCT01111604) | Eli Lilly and Company | 2010-08-01 |
| A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer (NCT01087970) | Eli Lilly and Company | 2010-08-01 |
| A Study of LY2541546 in Women With Low Bone Mineral Density (NCT01144377) | Eli Lilly and Company | 2010-08-01 |
| A Bioequivalence (BE) Study in Healthy Subjects (NCT01177943) | Eli Lilly and Company | 2010-08-01 |
| A Study in Erectile Dysfunction (NCT01130532) | Eli Lilly and Company | 2010-08-01 |
| Prasugrel Versus Placebo in Adult Sickle Cell Disease (NCT01167023) | Eli Lilly and Company | 2010-07-01 |
| Notch Inhibitor in Advanced Cancer (NCT01158404) | Eli Lilly and Company | 2010-07-01 |
| A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma (NCT01185548) | Eli Lilly and Company | 2010-07-01 |
| An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults (NCT01178099) | Eli Lilly and Company | 2010-07-01 |
| Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer (NCT01109524) | Eli Lilly and Company | 2010-07-01 |
| A Study in Participants With Diabetic Kidney Disease (NCT01113801) | Eli Lilly and Company | 2010-07-01 |
| A Study of Tadalafil in Benign Prostatic Hyperplasia (NCT01183650) | Eli Lilly and Company | 2010-07-01 |
| A Study in Head and Neck Cancer (NCT01081041) | Eli Lilly and Company | 2010-06-01 |
| An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma (NCT01137006) | Eli Lilly and Company | 2010-06-01 |
| A Long-Term, Open-Label, Study on Schizophrenia (NCT01129674) | Eli Lilly and Company | 2010-06-01 |
| A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes (NCT01149421) | Eli Lilly and Company | 2010-06-01 |
| A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents (NCT01127646) | Eli Lilly and Company | 2010-06-01 |
| A Study in Advanced Solid Tumors (NCT01063075) | Eli Lilly and Company | 2010-06-01 |
| A Safety Study of LY2886721 Single Doses in Healthy Subjects (NCT01133405) | Eli Lilly and Company | 2010-06-01 |
| A Study of LY2624587 in Patients With Advanced Cancer (NCT01139788) | Eli Lilly and Company | 2010-06-01 |
| A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors (NCT01131104) | Eli Lilly and Company | 2010-05-01 |
| Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients (NCT01115738) | Eli Lilly and Company | 2010-05-01 |
| A Study in Patients With Erectile Dysfunction (NCT01122264) | Eli Lilly and Company | 2010-05-01 |
| A Study in Rheumatoid Arthritis (NCT01253265) | Eli Lilly and Company | 2010-05-01 |
| Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer (NCT01107444) | Eli Lilly and Company | 2010-05-01 |
| A Study of Japanese Rheumatoid Arthritis Participants (NCT01253291) | Eli Lilly and Company | 2010-05-01 |
| Bioequivalence of Two Lispro Formulations (NCT01133392) | Eli Lilly and Company | 2010-05-01 |
| A Study of IMC-RON8 in Advanced Solid Tumors (NCT01119456) | Eli Lilly and Company | 2010-05-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) (NCT01126580) | Eli Lilly and Company | 2010-05-01 |
| A Study of LY2875358 in Participants With Advanced Cancer (NCT01287546) | Eli Lilly and Company | 2010-04-13 |
| A Study in Myeloproliferative Disorders (NCT01134120) | Eli Lilly and Company | 2010-04-01 |
| A Study in Men With Benign Prostatic Hyperplasia (NCT01097707) | Eli Lilly and Company | 2010-04-01 |
| A Study in Participants With Moderate to Severe Psoriasis (NCT01107457) | Eli Lilly and Company | 2010-04-01 |
| Study in Advanced Solid Tumors (NCT01099358) | Eli Lilly and Company | 2010-04-01 |
| Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use (NCT01109316) | Eli Lilly and Company | 2010-04-01 |
| A Study of LY2484595 in Patients With High LDL-C or Low HDL-C (NCT01105975) | Eli Lilly and Company | 2010-04-01 |
| Zyprexa® Relprevv™ Patient Care Program (NCT01088386) | Eli Lilly and Company | 2010-03-03 |
| A Study in Painful Diabetic Neuropathy (NCT01089556) | Eli Lilly and Company | 2010-03-01 |
| A Study in Schizophrenia Patients (NCT01086748) | Eli Lilly and Company | 2010-03-01 |
| A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients (NCT01253278) | Eli Lilly and Company | 2010-03-01 |
| A Study for Adolescents With Fibromyalgia Syndrome (NCT01089621) | Eli Lilly and Company | 2010-03-01 |
| Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease (NCT01107912) | Eli Lilly and Company | 2010-03-01 |
| A Study in Depression and Associated Painful Physical Symptoms (NCT01070329) | Eli Lilly and Company | 2010-03-01 |
| A Study in Patients With Advanced or Metastatic Cancer (NCT01115751) | Eli Lilly and Company | 2010-03-01 |
| A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors (NCT01115803) | Eli Lilly and Company | 2010-03-01 |
| Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (NCT01088503) | Eli Lilly and Company | 2010-03-01 |
| Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease (NCT01107925) | Eli Lilly and Company | 2010-03-01 |
| A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer (NCT01057589) | Eli Lilly and Company | 2010-02-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (NCT01064687) | Eli Lilly and Company | 2010-02-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) (NCT01075282) | Eli Lilly and Company | 2010-02-01 |
| A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus (NCT01029795) | Eli Lilly and Company | 2010-02-01 |
| A Phase 1 Study in Participants With Advanced Cancer (NCT01115790) | Eli Lilly and Company | 2010-02-01 |
| First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin (NCT00981058) | Eli Lilly and Company | 2010-01-07 |
| Study of IMC-11F8 in Participants With Advanced Solid Tumors (NCT01088464) | Eli Lilly and Company | 2010-01-01 |
| A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00918203) | Eli Lilly and Company | 2010-01-01 |
| A Study for Patients With Type 1 Diabetes (NCT01049412) | Eli Lilly and Company | 2010-01-01 |
| A Study of the Neurobiology of Depression (NCT01051466) | Eli Lilly and Company | 2010-01-01 |
| A Phase 1 Study of LY2787106 in Cancer and Anemia (NCT01340976) | Eli Lilly and Company | 2010-01-01 |
| A Study for Patients With Type 2 Diabetes (NCT01027871) | Eli Lilly and Company | 2010-01-01 |
| Observational Study in Japanese Type 2 Diabetes Patients (NCT01055808) | Eli Lilly and Company | 2010-01-01 |
| Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension (NCT01066845) | Eli Lilly and Company | 2010-01-01 |
| A Phase 1 Study of LY2835219 In Participants With Advanced Cancer (NCT01394016) | Eli Lilly and Company | 2009-12-07 |
| A Study of LY2599506 in Patients With Type 2 Diabetes (NCT01024244) | Eli Lilly and Company | 2009-12-01 |
| A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction (NCT01015287) | Eli Lilly and Company | 2009-12-01 |
| A Study of Semagacestat for Alzheimer's Patients (NCT01035138) | Eli Lilly and Company | 2009-12-01 |
| A Study for Participants With Small-Cell Lung Cancer (NCT01025284) | Eli Lilly and Company | 2009-12-01 |
| A Study for Adults With Plaque Psoriasis (NCT01018810) | Eli Lilly and Company | 2009-12-01 |
| A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma (NCT01006252) | Eli Lilly and Company | 2009-12-01 |
| First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin (NCT00982111) | Eli Lilly and Company | 2009-11-02 |
| Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes (NCT01017731) | Eli Lilly and Company | 2009-11-01 |
| A Study of IMC-A12 in Advanced Solid Tumors (NCT01007032) | Eli Lilly and Company | 2009-11-01 |
| A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer (NCT01005680) | Eli Lilly and Company | 2009-11-01 |
| A Study of Tadalafil After Radical Prostatectomy (NCT01026818) | Eli Lilly and Company | 2009-11-01 |
| A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients (NCT01020786) | Eli Lilly and Company | 2009-11-01 |
| A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder (NCT00969618) | Eli Lilly and Company | 2009-11-01 |
| A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis (NCT01018680) | Eli Lilly and Company | 2009-11-01 |
| A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer (NCT01017874) | Eli Lilly and Company | 2009-11-01 |
| A Study for the Transdermal Application of Teriparatide (NCT01011556) | Eli Lilly and Company | 2009-11-01 |